Actively Recruiting

Age: 18Years - 70Years
All Genders
NCT05030597

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

Led by Zhongnan Hospital · Updated on 2025-05-28

100

Participants Needed

1

Research Sites

224 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In this prospective study, the investigators will use integrated PET/CT with the agent 68Ga-FAPI and conventional imaging agent 18F-FDG to explore the application value of FAP-targeted molecular imaging in the diagnosis and staging for oral cancer. This study also aims to explore the application value of FAPI imaging in evaluating treatment response for oral cancer.

CONDITIONS

Official Title

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Voluntary participation with signed informed consent
  • Aged 18 to 70 years
  • Clinically highly suspected oral cancer or recurrence after treatment
  • Newly diagnosed patients scheduled for surgery or neoadjuvant therapy followed by surgery
  • Ability to complete baseline and follow-up PET/CT scans (follow-up applies for locally advanced patients receiving neoadjuvant therapy)
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women, or planning pregnancy during the trial
  • Known allergy or severe reaction to FAPI, FDG, or their components
  • Poor general health with heart, lung, liver, kidney, or other vital organ dysfunction preventing surgery
  • Fasting blood glucose level above 11.0 mmol/L before 18F-FDG injection
  • Claustrophobia or inability to lie still and tolerate PET/CT imaging for 15 to 30 minutes
  • Participation in another interventional clinical trial within 30 days before enrollment or planned during this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongnan Hopital of Wuhan University

Wuhan, Hubei, China, 430071

Actively Recruiting

Loading map...

Research Team

J

Jiang Yaqun, PhD

CONTACT

H

He Yong, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma | DecenTrialz